Results 201 to 210 of about 483,629 (260)

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden

open access: yesAdvanced Healthcare Materials, EarlyView.
Nanoemulsion delivery of a TLR7 agonist enhances safety and promotes colocalization with Leishmania‐infected macrophages in skin lesions, enabling a ∼2‐log reduction in parasite burden. However, tissue‐level constraints and TLR‐driven regulatory feedback generate a mixed immune response that limits complete parasite clearance.
Carmen Palomino‐Cano   +11 more
wiley   +1 more source

Changes in transverse dimensions in growing patients treated with AMCOP® and electromyographic assessment with Teethan®. [PDF]

open access: yesFront Dent Med
Ferrante L   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy